Abstract: Methods and compositions for use in treating, attenuating, preventing or improving liver fibrosis in a subject are described. The compounds of the present invention are gamma-ketoaldehyde scavengers.
Type:
Grant
Filed:
June 23, 2023
Date of Patent:
May 26, 2026
Assignee:
MTI Biotech, Inc.
Inventors:
John Rathmacher, Naji Abumrad, Charles Flynn
Abstract: Novel salicylamine derivatives are targeted directly to the mitochondria to increase effectiveness and lower required dosages in the treatment of conditions caused by inflammation or oxidative stress.
Type:
Grant
Filed:
January 27, 2020
Date of Patent:
October 7, 2025
Assignee:
MTI Biotech, Inc.
Inventors:
Kevin Moore, Michael P. Murphy, Naji Abumrad, John Fuller, Jr.
Abstract: Methods and compositions for use in treating, preventing or improving diseases related to the liver in an animal, including but not limited to nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) or nonalcoholic steatohepatitis (NASH), are described. The compounds of the present invention are gamma-ketoaldehyde scavengers.
Type:
Grant
Filed:
December 8, 2022
Date of Patent:
August 12, 2025
Assignee:
MTI Biotech, Inc.
Inventors:
John Rathmacher, Naji Abumrad, Charles Flynn